{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:06Z","timestamp":1786996326714,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.rmed.2025.108151","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:19:01Z","timestamp":1746724741000},"page":"108151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-5878","authenticated-orcid":false,"given":"Catherine","family":"Moermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Decerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Javaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Onssels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4523-1155","authenticated-orcid":false,"given":"No\u00e9mie","family":"Bricmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-9344","authenticated-orcid":false,"given":"Romane","family":"Bonhiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Rosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-5357","authenticated-orcid":false,"given":"Sara","family":"Gerday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-1978","authenticated-orcid":false,"given":"Makon-S\u00e9bastien","family":"Njock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Guissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ziant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9372-0654","authenticated-orcid":false,"given":"Carole","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2678-1373","authenticated-orcid":false,"given":"Florence","family":"Schleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.rmed.2025.108151_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2025.108151_bib2","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108151_bib3","series-title":"The Belgian Severe Asthma Registry (BSAR)","article-title":"Heterogeneity of phenotypes in severe asthmatics","author":"Schleich","year":"2014"},{"key":"10.1016\/j.rmed.2025.108151_bib4","article-title":"Overcoming barriers to remission in severe eosinophilic asthma: two-year real-world data with benralizumab","volume":"31","author":"Jackson","year":"2024","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.rmed.2025.108151_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.202405-0894ED","article-title":"Remission in the world of severe asthma","volume":"210","author":"Pavord","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108151_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108151_bib7","first-page":"1368","article-title":"Sputum type 2 markers could predict remission in severe asthma treated with anti-IL-5. Chest","volume":"163","author":"Moermans","year":"2023","journal-title":"juin"},{"issue":"11","key":"10.1016\/j.rmed.2025.108151_bib8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/thorax-2022-219781","article-title":"Super-responders to anti-IL-5\/anti-IL-5R are characterised by high sputum eosinophil counts at baseline","volume":"78","author":"Gerday","year":"2023","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2025.108151_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ni.1719","article-title":"Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma","volume":"10","author":"Goswami","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.rmed.2025.108151_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108151_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/thorax.2003.011130","article-title":"Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma","author":"Delvaux","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108151_bib12","doi-asserted-by":"crossref","DOI":"10.3791\/56612","article-title":"Methodology for sputum induction and laboratory processing","author":"Guiot","year":"2017","journal-title":"JoVE J."},{"key":"10.1016\/j.rmed.2025.108151_bib13","doi-asserted-by":"crossref","unstructured":"Martinez-Moragon E, Chiner E, Suliana Mogrovejo A, Palop Cervera M, Lluch Tortajada I, Boira Enrique I, et al. Real-world clinical remission of severe asthma with benralizumab in Spanish adults with severe asthma. J. Asthma :1-15. DOI: 10.1080\/02770903.2024.2332351.","DOI":"10.1080\/02770903.2024.2332351"},{"key":"10.1016\/j.rmed.2025.108151_bib14","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2147\/JAA.S474667","article-title":"Uncontrolled asthma is associated with increased visceral adipose tissue, decreased bone mineral content, and reduced exercise capacity","volume":"17","author":"Schleich","year":"2024","journal-title":"J. Asthma Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2025.108151_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chest.2020.08.2083","article-title":"Real-World effectiveness of benralizumab in severe eosinophilic asthma","volume":"159","author":"Kavanagh","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rmed.2025.108151_bib16","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1080\/02770903.2021.1963769","article-title":"Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients","volume":"59","author":"Watanabe","year":"2022","journal-title":"J Asthma 2 sept"},{"issue":"1","key":"10.1016\/j.rmed.2025.108151_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13223-015-0081-1","article-title":"Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma","volume":"11","author":"Chu","year":"2015","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108151_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cea.13085","article-title":"IL-6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function","volume":"48","author":"Turan","year":"2018","journal-title":"Clin Exp Allergy. avr"},{"issue":"2","key":"10.1016\/j.rmed.2025.108151_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2018.05.026","article-title":"Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation","volume":"143","author":"Jevnikar","year":"2019","journal-title":"J Allergy Clin Immunol. f\u00e9vr"},{"issue":"6","key":"10.1016\/j.rmed.2025.108151_bib20","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.jaci.2016.09.015","article-title":"Effect of aging on sputum inflammation and asthma control","volume":"139","author":"Busse","year":"2017","journal-title":"J Allergy Clin Immunol. juin"},{"issue":"4","key":"10.1016\/j.rmed.2025.108151_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/nnm-2022-0269","article-title":"Nanoparticles in induced sputum - a window to airway inflammation among active smokers","volume":"18","author":"Freund","year":"2023","journal-title":"Nanomedicine (Lond)."},{"issue":"1","key":"10.1016\/j.rmed.2025.108151_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00408-024-00760-9","article-title":"Increase in blood eosinophil count over time and sputum IL8 are associated with FEV1 decline in asthma","volume":"203","author":"Graff","year":"2024","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.rmed.2025.108151_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1165\/rcmb.2020-0168OC","article-title":"Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit","volume":"64","author":"Linssen","year":"2021","journal-title":"Am J Respir Cell Mol Biol. janv"},{"issue":"4","key":"10.1016\/j.rmed.2025.108151_bib24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.imbio.2019.05.006","article-title":"Airway smooth muscle cells are insensitive to the anti-proliferative effects of corticosteroids: the novel role of insulin growth factor binding Protein-1 in asthma","volume":"224","author":"Bui","year":"2019","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.rmed.2025.108151_bib25","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1038\/s41598-021-86179-1","article-title":"Blood tryptase and thymic stromal lymphopoietin levels predict the risk of exacerbation in severe asthma","volume":"11","author":"Ko","year":"2021","journal-title":"Sci Rep. 19 avr"},{"key":"10.1016\/j.rmed.2025.108151_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.836635","article-title":"Treatment resistance in severe asthma patients with a combination of high fraction of exhaled nitric oxide and low blood eosinophil counts","volume":"13","author":"Hoshino","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T23:24:33Z","timestamp":1762039473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"alternative-id":["S0954611125002136"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108151","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108151"}}